OxThera, founded in 2005 and headquartered in Stockholm, Sweden, is a biopharmaceutical company with products in late-stage clinical development focusing on Primary and Secondary Hyperoxaluria. OxThera’s intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes.
View Top Employees from OxThera| Website | http://www.oxthera.com |
| Revenue | $14 million |
| Funding | $44.6 million |
| Employees | 7 (6 on RocketReach) |
| Founded | 2005 |
| Phone | (468) 660-0223 |
| Technologies |
JavaScript,
HTML,
PHP
+14 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Health Care, Health Diagnostics |
| Web Rank | 20 Million |
| Keywords | Oxthera Inc, Oxabact |
| Competitors | Abivax, Alios BioPharma, Lumos Pharma, Neuraltus Pharmaceuticals, Patrys Limited |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular OxThera employee's phone or email?
OxThera Questions
The OxThera annual revenue was $14 million in 2023.
Ola Melin is the Director of Technical Operations of OxThera.
6 people are employed at OxThera.
The NAICS codes for OxThera are [54, 541714, 54171, 541, 5417].
The SIC codes for OxThera are [873, 87].
Top OxThera Employees
-
22
-
1
Related Companies
